Studies are showing that 26% of patients are losing as much of 30% or more of their base weight
Incretin mimetics (GLP-1 receptor agonists) consistently promote weight loss, with patients typically losing 26 kg over several months, making them particularly valuable for overweight individuals with type 2 diabetes
Frequently reported side effects are gastrointestinal, such as nausea, vomiting, diarrhea, constipation, stomach pain, and bloating, belching, and upset stomach
Whether a generic or cheaper equivalent is available
When these health issues are managed better, people may spend less money and lower their chance of other big problems, like heart disease or kidney failure
We're saying let consumers make an educated decision about it." Related Stories: WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugs Nationwide shortage of popular weight loss drugs being felt in Louisville area Diabetes medicine shortage in Louisville linked to nationwide weight loss trend Copyright 2024 WDRB Media